BioTuesdays

Category - Markets

Markets

SVB Leerink starts MannKind at OP; PT $3

SVB Leerink initiated coverage of MannKind (NASDAQ:MNKD) with an “outperform” rating and a 12-month price target of $3. The stock closed at $1.77 on March 1. Analyst Dr. Pasha Sarraf writes that his rating is based on...

March 4, 2019
OpGen Logo
Markets

AGP starts OpGen at buy; PT $2.30

AGP/Alliance Global Partners launched coverage of OpGen (NASDAQ:OPGN) with a “buy” rating and price target of $2.30. The stock closed at $1.48 on March 1. “OpGen’s approach to antibiotic resistance identification...

March 4, 2019
Albireo Pharma Logo
Markets

HCW starts Albireo Pharma at buy; PT $62

H.C. Wainwright launched coverage of Albireo Pharma (NASDAQ:ALBO) with a “buy” rating and $27 price target. The stock closed at $26.80 on Feb. 27. Albireo is focused on rare pediatric and adult cholestatic diseases...

February 28, 2019
Corindus Logo
Markets

Corindus Vascular Robotics closes private placement

Corindus Vascular Robotics (NYSE American:CVRS) privately sold 10,872,716 of its common shares at a price of $1.3796 each to a large institutional investor for gross proceeds of about $15-million. Net proceeds of about...

February 26, 2019
Pulse Biosciences Logo
Markets

HCW starts Pulse Biosciences at buy; PT $27

H.C. Wainwright launched coverage of Pulse Biosciences (NASDAQ:PLSE) with a “buy” rating and price target of $27. The stock closed at $18.23 on Feb. 22. Analyst Swayampakula Ramakanth writes that his recommendation is...

February 25, 2019
BioTime
Markets

HCW starts BioTime at buy; PT $4

H.C. Wainwright launched coverage of BioTime (NYSE American:BTX) with a “buy” rating and $4 price target. The stock closed at $1.15 on Feb. 20. Analyst Joseph Pantginis writes that BioTime was originally focused on...

February 21, 2019
Arcturus Logo
Markets

Roth starts Arcturus Therapeutics at buy; PT $14

Roth Capital Partners launched coverage of Arcturus Therapeutics (NASDAQ:ARCT) with a “buy” rating and $14 price target. The stock closed at $4.84 on Feb. 19. “Arcturus is a hidden gem in a sea of RNA medicines...

February 20, 2019